| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| acamprosate | gamma-aminobutyric acid type b receptor subunit 1 | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.92 | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.71 | approved,investigational | antagonist |
| acamprosate | glutamate (nmda) receptor | small molecule | NA | drugbank | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| acamprosate | metabotropic glutamate receptor 5 | small molecule | NA | drugbank , DGIDB | Alcoholic Intoxication Chronic[MeSHID:D000437] Alcohol Abstinence[MeSHID:D064829] Maintenance[MeSHID:D008283] Metabolic Detoxication Drug[MeSHID:D008658] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.23 | approved,investigational | antagonist |
| click here to return to the previous page | ||||||||